Clinical trial
A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002 (IMPAHCT-FUL)
NCT05557942 is registered in ClinicalTrials.gov with Aerovate Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002 (IMPAHCT-FUL)
- Lead sponsor
- Aerovate Therapeutics
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 2, 2022
- Completion date
- August 8, 2024
- Enrollment
- 186 (actual)
- Sites
- 72
Conditions
As the registry lists them; a condition with its own page is linked.